It is about having a provider who can assess whether the compound is working, whether the dose is appropriate for the specific injury and patient profile, and whether the response at weeks four and eight warrants continuing, adjusting, or pausing
Indeed, IDH1 inhibition or glutamine starvation in MYC-overexpressing cells decreased KG abundance (Extended Data Fig
Honestly, it varies, and anyone promising an exact timeline is guessing
Pros: Much cheaper ($150$500/month depending on dose), no prescription needed, widely available Cons: No quality control, contamination risk, no medical oversight, legal ambiguity, no recourse if something goes wrong Risk mitigation: Third-party testing (Janoshik or similar labs), vet vendors through Reddit/peptide forums, start with small orders Grey Market Risks Research peptides are not regulated by the FDA
Key warning signs include pins and needles or numbness in hands and feet, balance problems, memory difficulties, persistent fatigue disproportionate to weight loss, shortness of breath, and pale appearance
They were removed to 25C and were shaken overnight
